Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Wet Age Related Macular Degeneration (AMD) market report explains the definition, types, applications, major countries, and major players of the Wet Age Related Macular Degeneration (AMD) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
StemCell (Canada)
Allergan (Ireland)
Bayer (Germany)
Alimera Sciences (US)
Regeneron Pharmaceutical (US)
Ophthotech (US)
Gilead Sciences (US)
Neurotech Pharmaceuticals (US)
Adverum Biotechnologies (US)
Novartis International (Switzerland)
GlaxoSmithKline (US)
F Hoffmann-La Roche (Switzerland)
Acucela (US)
By Type:
Wet Age-Related Macular Degeneration (Wet AMD)
Dry Age-Related Macular Degeneration (Dry AMD)
By End-User:
>75 Years
>60 Years
>40 Years
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Wet Age Related Macular Degeneration (AMD) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Wet Age Related Macular Degeneration (AMD) Outlook to 2028- Original Forecasts
-
2.2 Wet Age Related Macular Degeneration (AMD) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Wet Age Related Macular Degeneration (AMD) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Wet Age Related Macular Degeneration (AMD) Market- Recent Developments
-
6.1 Wet Age Related Macular Degeneration (AMD) Market News and Developments
-
6.2 Wet Age Related Macular Degeneration (AMD) Market Deals Landscape
7 Wet Age Related Macular Degeneration (AMD) Raw Materials and Cost Structure Analysis
-
7.1 Wet Age Related Macular Degeneration (AMD) Key Raw Materials
-
7.2 Wet Age Related Macular Degeneration (AMD) Price Trend of Key Raw Materials
-
7.3 Wet Age Related Macular Degeneration (AMD) Key Suppliers of Raw Materials
-
7.4 Wet Age Related Macular Degeneration (AMD) Market Concentration Rate of Raw Materials
-
7.5 Wet Age Related Macular Degeneration (AMD) Cost Structure Analysis
-
7.5.1 Wet Age Related Macular Degeneration (AMD) Raw Materials Analysis
-
7.5.2 Wet Age Related Macular Degeneration (AMD) Labor Cost Analysis
-
7.5.3 Wet Age Related Macular Degeneration (AMD) Manufacturing Expenses Analysis
8 Global Wet Age Related Macular Degeneration (AMD) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Wet Age Related Macular Degeneration (AMD) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Wet Age Related Macular Degeneration (AMD) Export by Region (Top 10 Countries) (2017-2028)
9 Global Wet Age Related Macular Degeneration (AMD) Market Outlook by Types and Applications to 2022
-
9.1 Global Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Wet Age-Related Macular Degeneration (Wet AMD) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dry Age-Related Macular Degeneration (Dry AMD) Consumption and Growth Rate (2017-2022)
-
9.2 Global Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global >75 Years Consumption and Growth Rate (2017-2022)
-
9.2.2 Global >60 Years Consumption and Growth Rate (2017-2022)
-
9.2.3 Global >40 Years Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Wet Age Related Macular Degeneration (AMD) Market Analysis and Outlook till 2022
-
10.1 Global Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.2.2 Canada Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.2.3 Mexico Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.2 UK Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.3 Spain Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.4 Belgium Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.5 France Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.6 Italy Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.7 Denmark Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.8 Finland Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.9 Norway Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.10 Sweden Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.11 Poland Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.12 Russia Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.3.13 Turkey Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.2 Japan Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.3 India Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.4 South Korea Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.5 Pakistan Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.6 Bangladesh Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.7 Indonesia Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.8 Thailand Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.9 Singapore Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.10 Malaysia Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.11 Philippines Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.4.12 Vietnam Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5.2 Colombia Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5.3 Chile Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5.4 Argentina Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5.5 Venezuela Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5.6 Peru Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5.7 Puerto Rico Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.5.8 Ecuador Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.6.2 Kuwait Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.6.3 Oman Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.6.4 Qatar Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.7.2 South Africa Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.7.3 Egypt Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.7.4 Algeria Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
-
10.8.2 New Zealand Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)
11 Global Wet Age Related Macular Degeneration (AMD) Competitive Analysis
-
11.1 StemCell (Canada)
-
11.1.1 StemCell (Canada) Company Details
-
11.1.2 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.1.4 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Allergan (Ireland)
-
11.2.1 Allergan (Ireland) Company Details
-
11.2.2 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.2.4 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Bayer (Germany)
-
11.3.1 Bayer (Germany) Company Details
-
11.3.2 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.3.4 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Alimera Sciences (US)
-
11.4.1 Alimera Sciences (US) Company Details
-
11.4.2 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.4.4 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Regeneron Pharmaceutical (US)
-
11.5.1 Regeneron Pharmaceutical (US) Company Details
-
11.5.2 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.5.4 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Ophthotech (US)
-
11.6.1 Ophthotech (US) Company Details
-
11.6.2 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.6.4 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Gilead Sciences (US)
-
11.7.1 Gilead Sciences (US) Company Details
-
11.7.2 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.7.4 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Neurotech Pharmaceuticals (US)
-
11.8.1 Neurotech Pharmaceuticals (US) Company Details
-
11.8.2 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.8.4 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Adverum Biotechnologies (US)
-
11.9.1 Adverum Biotechnologies (US) Company Details
-
11.9.2 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.9.4 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Novartis International (Switzerland)
-
11.10.1 Novartis International (Switzerland) Company Details
-
11.10.2 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.10.4 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 GlaxoSmithKline (US)
-
11.11.1 GlaxoSmithKline (US) Company Details
-
11.11.2 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.11.4 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 F Hoffmann-La Roche (Switzerland)
-
11.12.1 F Hoffmann-La Roche (Switzerland) Company Details
-
11.12.2 F Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 F Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.12.4 F Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Acucela (US)
-
11.13.1 Acucela (US) Company Details
-
11.13.2 Acucela (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Acucela (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
11.13.4 Acucela (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Wet Age Related Macular Degeneration (AMD) Market Outlook by Types and Applications to 2028
-
12.1 Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Wet Age-Related Macular Degeneration (Wet AMD) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Dry Age-Related Macular Degeneration (Dry AMD) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global >75 Years Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global >60 Years Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global >40 Years Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Wet Age Related Macular Degeneration (AMD) Market Analysis and Outlook to 2028
-
13.1 Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.2.2 Canada Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.2 UK Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.3 Spain Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.5 France Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.6 Italy Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.8 Finland Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.9 Norway Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.11 Poland Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.12 Russia Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.2 Japan Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.3 India Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5.3 Chile Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5.6 Peru Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.6.3 Oman Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Wet Age Related Macular Degeneration (AMD)
-
Figure of Wet Age Related Macular Degeneration (AMD) Picture
-
Table Global Wet Age Related Macular Degeneration (AMD) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Wet Age Related Macular Degeneration (AMD) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Wet Age-Related Macular Degeneration (Wet AMD) Consumption and Growth Rate (2017-2022)
-
Figure Global Dry Age-Related Macular Degeneration (Dry AMD) Consumption and Growth Rate (2017-2022)
-
Figure Global >75 Years Consumption and Growth Rate (2017-2022)
-
Figure Global >60 Years Consumption and Growth Rate (2017-2022)
-
Figure Global >40 Years Consumption and Growth Rate (2017-2022)
-
Figure Global Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Table North America Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Figure United States Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Canada Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Table Europe Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Figure Germany Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure UK Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Spain Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure France Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Italy Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Finland Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Norway Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Poland Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Russia Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Table APAC Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Figure China Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Japan Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure India Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Table South America Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Figure Brazil Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Chile Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Peru Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Table GCC Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Figure Bahrain Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Oman Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Table Africa Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Figure Nigeria Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Table Oceania Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)
-
Figure Australia Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)
-
Table StemCell (Canada) Company Details
-
Table StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Allergan (Ireland) Company Details
-
Table Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Bayer (Germany) Company Details
-
Table Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Alimera Sciences (US) Company Details
-
Table Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Regeneron Pharmaceutical (US) Company Details
-
Table Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Ophthotech (US) Company Details
-
Table Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Gilead Sciences (US) Company Details
-
Table Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Neurotech Pharmaceuticals (US) Company Details
-
Table Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Adverum Biotechnologies (US) Company Details
-
Table Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Novartis International (Switzerland) Company Details
-
Table Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table GlaxoSmithKline (US) Company Details
-
Table GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table F Hoffmann-La Roche (Switzerland) Company Details
-
Table F Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table F Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Table Acucela (US) Company Details
-
Table Acucela (US) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acucela (US) Wet Age Related Macular Degeneration (AMD) Main Business and Markets Served
-
Table Acucela (US) Wet Age Related Macular Degeneration (AMD) Product Portfolio
-
Figure Global Wet Age-Related Macular Degeneration (Wet AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dry Age-Related Macular Degeneration (Dry AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global >75 Years Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global >60 Years Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global >40 Years Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Table North America Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Figure United States Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Figure Germany Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Figure China Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)
-
Figure Australia Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)
-
